Vanguard Health Care ETF (VHT)
171.97
-2.03 -1.17%
NYSE Arca
Oct 19, 20:00
Delayed 2m
USD
VHT Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
| 1 Year Fund Level Flows | Upgrade |
View All VHT News
VHT News
-
WireHeadlineTime (ET)
-
MT Newswires10/19 13:23
-
MT Newswires10/19 09:25
-
MT Newswires10/18 13:49
-
MT Newswires10/18 09:23
-
MT Newswires10/17 13:30
-
MT Newswires10/17 09:20
-
MT Newswires10/16 13:20
-
MT Newswires10/16 09:25
-
SA Breaking News10/15 13:49
-
MT Newswires10/15 13:26
VHT Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | -2.86% | -2.78% | -4.95% | 27 |
| 3M | 3.81% | 3.86% | -1.75% | 12 |
| 6M | 11.12% | 11.11% | 7.66% | 21 |
| YTD | 12.64% | 12.68% | 10.94% | 31 |
| 1Y | 12.01% | 12.03% | 10.94% | 38 |
| 3Y | 11.64% | 11.64% | 8.81% | 22 |
| 5Y | 13.86% | 13.87% | 12.65% | 32 |
| 10Y | 15.87% | 15.94% | 16.13% | 51 |
VHT Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.39% | 0.39% | 0.00% |
| Stock | 99.61% | 99.61% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
VHT Region Exposure
| Americas | 99.93% |
| North America | 99.92% |
| Latin America | 0.01% |
| Greater Europe | 0.05% |
| United Kingdom | 0.00% |
| Europe Developed | 0.05% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
VHT Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.02% |
| Healthcare | 98.34% |
| Industrials | 0.07% |
| Real Estate | 0.00% |
| Technology | 1.56% |
| Utilities | 0.00% |
VHT Stock Market Capitalization
| Giant | 46.64% |
| Large | 33.73% |
| Medium | 13.80% |
| Small | 5.26% |
| Micro | 0.56% |
VHT Stock Style Exposure
| Large Cap Value | 24.16% |
| Large Cap Blend | 32.44% |
| Large Cap Growth | 24.15% |
| Mid Cap Value | 1.45% |
| Mid Cap Blend | 2.63% |
| Mid Cap Growth | 9.71% |
| Small Cap Value | 0.35% |
| Small Cap Blend | 1.56% |
| Small Cap Growth | 3.55% |
View More Holdings
As of Sept. 30, 2018
VHT Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.51% | 139.05 | -0.32% |
| PFE | Pfizer Inc | 5.92% | 44.50 | +1.14% |
| UNH | UnitedHealth Group Inc | 5.87% | 265.30 | -0.57% |
| MRK | Merck & Co Inc | 4.38% | 72.35 | +0.19% |
| ABBV | AbbVie Inc | 3.30% | 87.97 | -2.15% |
| AMGN | Amgen Inc | 3.15% | 201.80 | -0.45% |
| MDT | Medtronic PLC | 3.06% | 93.94 | -2.06% |
| ABT | Abbott Laboratories | 2.96% | 67.59 | -0.81% |
| LLY | Eli Lilly and Co | 2.41% | 111.92 | -1.23% |
| BMY | Bristol-Myers Squibb Company | 2.33% | 54.30 | -3.00% |
Advertisement
VHT One Page Reports
- One Page Report Download
VHT Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
|---|---|
MSCI US IMI/Health Care 25-50 GR USD |
100.0% |
VHT Manager Info
| Name | Tenure |
|---|---|
| Michelle Louie | 0.75 yrs |
| Walter Nejman | 2.70 yrs |
VHT Net Fund Flows
| 1M | 248.99M |
| 3M | 750.30M |
| 6M | 748.83M |
| YTD | 731.05M |
| 1Y | 766.46M |
| 3Y | 1.209B |
| 5Y | 4.344B |
| 10Y | 5.303B |
VHT Risk Info
| Beta (5Y) | 0.9301 |
| Max Drawdown (All) | 39.01% |
| Historical Sharpe (10Y) | 1.172 |
| Historical Sortino (All) | 0.9814 |
| 30-Day Rolling Volatility | 16.83% |
| Daily Value at Risk (VaR) 1% (All) | 2.89% |
| Monthly Value at Risk (VaR) 1% (All) | 12.76% |
VHT Fundamentals
| Dividend Yield TTM (10-19-18) | 1.26% |
| 30-Day SEC Yield (10-19-18) | 1.46% |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 29.48 |
| Weighted Average Price to Sales Ratio | 1.997 |
| Weighted Average Price to Book Ratio | 4.320 |
| Weighted Median ROE | 13.61% |
| Weighted Median ROA | 4.03% |
| Forecasted Dividend Yield | 1.34% |
| Forecasted PE Ratio | 18.02 |
| Forecasted Price to Sales Ratio | 1.917 |
| Forecasted Price to Book Ratio | 3.998 |
| Number of Holdings | 370 |
VHT Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.41% |
| Forecasted Book Value Growth | 6.52% |
| Forecasted Cash Flow Growth | 7.15% |
| Forecasted Earnings Growth | -1.72% |
| Forecasted Revenue Growth | 8.67% |
VHT Attributes
| Key Dates | |
|---|---|
| Inception Date | 1/26/2004 |
| Termination Date | |
| Last Annual Report Date | 8/31/2017 |
| Last Prospectus Date | 12/21/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
VHT Excel Add-In Codes
- Name: =YCI("VHT","name")
- Broad Asset Class: =YCI("VHT", "broad_asset_class")
- Broad Category: =YCI("VHT", "broad_category_group")
- Prospectus Objective: =YCI("VHT", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
